Publications by authors named "Elina Kaprio"

Background: Rituximab-based combinations are the standard of care in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL). Despite being on market for over 20 years, some of the adverse effects associated with the use of rituximab are not well known. Drug-induced interstitial pneumonitis (DIP) is a potentially fatal complication of the treatment.

View Article and Find Full Text PDF
Article Synopsis
  • * High-risk patients are recommended to receive CNS prophylaxis, but there is no clear agreement on who qualifies as "high-risk" or the best prophylactic method.
  • * A study of 95 high-risk DLBCL patients showed that using high-dose methotrexate with R-CHOP significantly reduced CNS relapse rates (5% with prophylaxis vs. 26% without), indicating it may help prevent CNS failures.
View Article and Find Full Text PDF